EyePoint Pharmaceuticals Inc

NASDAQ:EYPT   3:59:44 PM EDT
8.79
-0.06 (-0.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)252.63M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.26 Million
Adjusted EPS-$0.43
See more estimates
10-Day MA$9.43
50-Day MA$10.11
200-Day MA$7.73
See more pivots

EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT

480 Pleasant Street, Suite B300, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.926.5000
Number of Employees: 101

Description

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.